exRNAdisease

Entry Detail

---



General Information

Database ID: exR0087358 RNA Name: hsa-miR-27a-3p RNA Type: miRNA Chromosome: chr19 Starnd: - Coordinate: Start Site(bp): 13836447 End Site(bp): 13836467 External Links: hsa-miR-27a-3p

Disease Information

Disease Name: Moyamoya Disease Disease Category: Nervous System Diseases MeSH ID: D009072 Type: Diseases Category/Nervous System Diseases Alias: Progressive Intracranial Occlusive Arteropathy (Moyamoya)//Moyamoya Syndrome//Moya-Moya Disease//Disease, Moya-Moya//Moya Moya Disease//Cerebrovascular Moyamoya Disease//Moyamoya Disease, Primary//Disease, Primary Moyamoya//Moyamoya Diseases, Primary//Primary Moyamoya Disease//Primary Moyamoya Diseases//Moyamoya Disease, Classic//Classic Moyamoya Disease//Disease, Classic Moyamoya//Moyamoya Disease, Secondary//Secondary Moyamoya Disease

Expression Detail

GEO ID: GSE100488 Description: Circulating miRNome profiling in Moyamoya disease-discordant monozygotic twins Experimental Design: Disease vs Control Case Disease Type: Moyamoya Disease Case Disease SubType: NA Case Sample: Moyamoya Disease Control Sample: Normal Number of Case: 11 Number of Control: 10 Number of Samples: 21

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand IGF2BP3 chr7 23310209 23470491 - SOX11 chr2 5692384 5701385 + AEN chr15 88621337 88632281 + SUCO chr1 172532349 172611833 + ALDH3A2 chr17 19648136 19685760 + CD2AP chr6 47477789 47627263 + TTYH3 chr7 2631986 2664802 + C1orf116 chr1 207018522 207032756 - GLTP chr12 109850945 109880541 - PAX9 chr14 36657568 36679362 + TMEM30A chr6 75252924 75284948 - NUAK1 chr12 106063340 106140033 - LGALS8 chr1 236518000 236552981 + ACER3 chr11 76860867 77026797 + NEK2 chr1 211658657 211675630 - CDR2 chr16 22345936 22437165 - B4GALT3 chr1 161171310 161177968 - JRK chr8 142657460 142681968 - KCNK1 chr1 233614106 233672514 + ACLY chr17 41866917 41930542 - TMX4 chr20 7977346 8019805 - PPP1CC chr12 110719680 110742939 - KPNA6 chr1 32108056 32176563 + HTT chr4 3041422 3243960 + NF1 chr17 31094927 31382116 + ETNK1 chr12 22625075 22690665 + ZBTB34 chr9 126860665 126885878 + CANX chr5 179678628 179731641 + PAK1 chr11 77321707 77474635 - GIPC1 chr19 14477760 14496149 - miRNA targets: NA circRNA targets: circRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa_circ_0000384 chr12 27867712 27877119 + hsa_circ_0001247 chr22 46125304 46136418 + hsa_circ_0000942 chr19 46020920 46021352 + lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC010980.2 chr2 222317242 222318653 - AC021092.1 chr19 44103007 44113183 - AC022150.4 chr19 52650437 52653284 - AC093010.3 chr3 114314501 114329714 - AL050341.2 chr1 40256427 40257967 - KCNQ1OT1 chr11 2608328 2699994 - LINC01089 chr12 121795267 121803906 - LINC02381 chr12 54126082 54147485 + NEAT1 chr11 65422774 65445540 + SDCBP2-AS1 chr20 1325405 1378735 + SNHG22 chr18 49814023 49851059 + TUG1 chr22 30969245 30979395 + XIST chrX 73820649 73852723 - Display:

Experiment Detail

GEO ID: GSE100488 Sample Source: Blood Source Fraction: Plasma Platform: GPL20712 Method: Microarray Num of detected RNA Type: 1 Num of detected RNAs of this Type: 291 Sample treatment protocol: Whole blood samples were collected into disodium ethylenediaminotetraacetate tubes, centrifuged (4 °C, 3000 rpm, 30 minutes) immediately for plasma. RNA Extract protocol: Total RNA was isolated from 200 uL of the pooled plasma using miRNeasy Serum/Plasma Kit (QIAGEN, Hilden, Germany). RNA library preparation protocol: Cyanine 3-pCp-labeled microRNA was prepared from 2-uL of total RNA isolated from 200-uL of plasma, using Agilent's miRNA Complete Labeling and Hyb Kit (part number 5190-0456).

Reference

PMID: 30157848 Title: Circulating miRNome profiling in Moyamoya disease-discordant monozygotic twins and endothelial microRNA expression analysis using iPS cell line Author: Uchino H, Ito M, Kazumata K, Hama Y, Hamauchi S, Terasaka S, Sasaki H, Houkin K Journal: BMC Med Genomics. 2018 Aug 29;11(1):72. Description: we employed a disease discordant monozygotic twin-based study design to unmask potential confounders.